Thank you for coming to
the Gilead Sciences Consent and Preference Portal.

1

Email & Consent

2

Validation

3

Therapy Area Preferences

4

Confirmation

Please complete and submit the form below to provide
your consent to receive [electronic] marketing
communications from Gilead

* I accept the terms and conditions below

By clicking on consent below, you consent to receive electronic marketing communications from Gilead Sciences Ltd (company registered in England under number 02543818 with registered address at 280 High Holborn, London, WC1V 7EE) and its affiliates. This may include information about Gilead medicines and services, educational events and congresses, and news about Gilead or the healthcare environment.

Gilead may share your personal data with third party vendors who provide services to Gilead for the purposes of providing you with information you have agreed to receive, or a means by which you can change your communication preferences. Gilead shall remain responsible for the confidentiality and security of your personal data at all times.

Gilead is the controller of the personal data you have provided in this form, which we will hold in order to send you electronic marketing communications. Please see our Privacy Statement for further information about how we process your data and what your rights are.

You may opt-out of receiving electronic marketing communications, at any time, by contacting us at [email protected] or clicking the unsubscribe or preference centre links on any communications sent to you.

Note that Gilead may email you important product safety updates when required to do so by law or regulatory authority, including where you have not given consent or have opted out from receiving marketing communications.